A Growing Industry Built by People Who Have Never Treated a Patient
Health technology has become one of the more crowded categories in venture-backed startups. A large share of the founders building in it have never treated a patient, written a prescription, or sat across from someone trying to explain a symptom they cannot quite describe.
Of course, plenty of good healthcare products have been built by founders with strong technical or operational backgrounds and no clinical training at all.
Myra Ahmad, the founder and CEO of Mochi Health, represents a different path into the category, and she has argued that path matters more in healthcare than it does almost anywhere else a founder might build a company.
Ahmad earned her MD from the University of Washington School of Medicine and conducted research at MIT and UCSF before founding Mochi Health in 2022, identifying what she has described as a critical gap in obesity care delivery.
Patients bounce between bariatric practices, endocrinology, and primary care without anyone actually treating the underlying disease.
What Clinical Training Actually Changes About Product Decisions
Myra Ahmad does not see patients herself. Mochi Health’s clinical care is delivered by the physicians and other licensed clinicians employed through the company’s medical entities.
Mochi’s argument is narrower and more specific. A founder who has actually practiced medicine understands, in a way a founder without that training cannot, where a product decision that looks efficient on a spreadsheet actually breaks down in a real clinical encounter.
A founder without clinical training might look at a prescribing workflow and see an opportunity to remove a step that seems redundant. A founder with clinical training is more likely to recognize that the step exists because it is the moment a provider catches a contraindication, a dosing concern, or a detail in a patient’s history that an intake form alone would have missed.
That difference shows up constantly in the decisions a health tech company makes about where to add friction, where to remove it, and where automation is genuinely safe versus where it quietly removes a safeguard nobody outside of clinical practice would notice was missing.
The Gap Ahmad Has Pointed to in Her Own Category
The specific gap that shaped Ahmad’s path into founding Mochi Health is itself the kind of problem that is easier to spot from inside clinical practice than from outside it.
A founder analyzing the telehealth market from a business or technology background might see fragmented care as an operational inefficiency worth solving with better scheduling software or a more seamless referral system.
A founder who trained clinically is more likely to recognize that the deeper issue is not logistics but ownership: no single provider was treating the whole patient, which is a clinical failure, not just a coordination one.
A company solving the logistics problem might build a better appointment booking tool. A company solving the ownership problem builds a structure where one care team, physician and dietitian together, stays with a patient across their treatment, which is closer to what Mochi Health has actually built.
Where This Argument Has Limits
Ahmad’s position is not that clinical training is the only qualification that matters for a health tech founder, or that founders without it cannot build good products.
Plenty of the infrastructure a healthcare company needs does not require a medical degree to execute well. Mochi Health itself depends on expertise well beyond clinical training to function at all.
The argument is specifically about judgment at the margins. A founder without that training can compensate by building close relationships with clinical advisors and deferring genuinely to their judgment.
A founder with clinical training built in from the start has that judgment available at the table for every decision, not just the ones that get escalated to a medical advisory board after the fact.
Why This Argument Matters Beyond One Founder’s Resume
None of this is really about Ahmad’s own credentials for their own sake. It is an argument about how healthcare products end up shaped by whoever is making the underlying decisions, and about what is lost when none of those decision makers have ever actually practiced the medicine the product is meant to deliver.
A health tech company can hire clinicians into advisory roles, and many do, but an advisor brought in after a product’s core assumptions are already set has a different kind of influence than a founder whose clinical training shaped those assumptions from the beginning.
That is the case Myra Ahmad has made, implicitly through how she built Mochi Health: That healthcare products built by people who have actually practiced medicine tend to get the hard judgment calls right more often, not because clinical training makes someone infallible, but because it gives a founder a working knowledge of exactly where the real risks in a clinical workflow actually sit.
There is also a longer-term argument buried in this position, one about where the next generation of health tech founders should come from.
If clinical training genuinely produces better judgment on the decisions that matter most in healthcare products, the pipeline of founders in this category should look less like a subset of general technology entrepreneurship and more like a distinct track that starts with, or at least deliberately incorporates, real clinical experience.
That is a harder pipeline to build than simply recruiting technical talent into healthcare, because clinical training takes years and cannot be compressed into a bootcamp or an advisory retainer.
Ahmad’s own path suggests one version of what that pipeline could look like.
It is not the only version, and it is not a requirement for every person who wants to build in health tech. It is, in her framing, the version most likely to produce products that hold up under the weight of what they are actually being asked to do: manage real medical decisions for real patients, not just move data between screens.